Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

847 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment.
Beelen K, Opdam M, Severson TM, Koornstra RH, Vincent AD, Hauptmann M, van Schaik RH, Berns EM, Vermorken JB, van Diest PJ, Linn SC. Beelen K, et al. Among authors: van diest pj, van schaik rh. Breast Cancer Res Treat. 2013 Jun;139(3):649-55. doi: 10.1007/s10549-013-2568-0. Epub 2013 Jun 5. Breast Cancer Res Treat. 2013. PMID: 23736997 Free PMC article. Clinical Trial.
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.
van der Heiden-van der Loo M, de Munck L, Sonke GS, van Dalen T, van Diest PJ, van den Bongard HJ, Peeters PH, Rutgers EJ. van der Heiden-van der Loo M, et al. Among authors: van den bongard hj, van diest pj, van dalen t. Eur J Cancer. 2015 May;51(8):915-21. doi: 10.1016/j.ejca.2015.03.014. Epub 2015 Apr 6. Eur J Cancer. 2015. PMID: 25857549
Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer.
Aalders KC, van Bommel AC, van Dalen T, Sonke GS, van Diest PJ, Boersma LJ, van der Heiden-van der Loo M. Aalders KC, et al. Among authors: van der heiden van der loo m, van bommel ac, van diest pj, van dalen t. Eur J Cancer. 2016 Aug;63:118-26. doi: 10.1016/j.ejca.2016.05.010. Epub 2016 Jun 11. Eur J Cancer. 2016. PMID: 27299664
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells.
Pinedo HM, Buter J, Luykx-de Bakker SA, Pohlmann PR, van Hensbergen Y, Heideman DA, van Diest PJ, de Gruijl TD, van der Wall E. Pinedo HM, et al. Among authors: van hensbergen y, van der wall e, van diest pj. Eur J Cancer. 2003 May;39(8):1061-7. doi: 10.1016/s0959-8049(03)00131-x. Eur J Cancer. 2003. PMID: 12736104
Current technologies for HER2 testing in breast cancer.
Moelans CB, de Weger RA, Van der Wall E, van Diest PJ. Moelans CB, et al. Among authors: van der wall e, van diest pj. Crit Rev Oncol Hematol. 2011 Dec;80(3):380-92. doi: 10.1016/j.critrevonc.2010.12.005. Epub 2011 Jan 26. Crit Rev Oncol Hematol. 2011. PMID: 21273092 Review.
Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient.
Hoefnagel LD, van der Groep P, van de Vijver MJ, Boers JE, Wesseling P, Wesseling J; Dutch Distant Breast Cancer Metastases Consortium; van der Wall E, van Diest PJ. Hoefnagel LD, et al. Among authors: van der groep p, van der wall e, van de vijver mj, van diest pj. Ann Oncol. 2013 Dec;24(12):3017-23. doi: 10.1093/annonc/mdt390. Epub 2013 Oct 10. Ann Oncol. 2013. PMID: 24114857 Free article.
St. Gallen endocrine response classes predict recurrence rates over time.
Koornstra RH, Beelen KJ, Vincent AD, van der Noort V, van Diest PJ, Linn SC. Koornstra RH, et al. Among authors: van diest pj, van der noort v. Breast. 2015 Dec;24(6):705-12. doi: 10.1016/j.breast.2015.08.009. Epub 2015 Oct 1. Breast. 2015. PMID: 26429398 Clinical Trial.
The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer.
van Steenhoven JEC, Kuijer A, Schreuder K, Elias SG, van Diest PJ, van der Wall E, Siesling S, van Dalen T. van Steenhoven JEC, et al. Among authors: van der wall e, van diest pj, van dalen t. Ann Surg Oncol. 2019 Oct;26(11):3495-3501. doi: 10.1245/s10434-019-07511-8. Epub 2019 Jun 17. Ann Surg Oncol. 2019. PMID: 31209664 Free PMC article.
847 results